Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 3,879,099 | 3,601,100 | 3,667,700 | 3,497,400 | 3,644,300 |
| Cost of Goods | 898,200 | 845,700 | 871,300 | 859,000 | 865,700 |
| Gross Profit | 2,980,899 | 2,755,400 | 2,796,400 | 2,638,400 | 2,778,600 |
| Operating Expenses | 1,999,700 | 1,822,600 | 1,908,800 | 1,792,600 | 1,834,301 |
| Operating Income | 981,400 | 933,500 | 887,900 | 845,800 | 945,000 |
| Other Income | -86,700 | 85,000 | -1,028,000 | 98,600 | -425,000 |
| Pre-tax Income | 894,700 | 1,018,500 | -140,100 | 944,400 | 520,000 |
| Income Tax | 172,100 | 224,100 | 111,900 | 207,800 | 522,400 |
| Net Income Continuous | 722,600 | 794,400 | -252,000 | 736,600 | -2,400 |
| Net Income | $700,600 | $794,400 | $-252,000 | $736,600 | $-2,400 |
| EPS Basic Total Ops | 0.64 | 0.73 | -0.23 | 0.68 | -0.01 |
| EPS Basic Continuous Ops | 0.66 | 0.73 | -0.23 | 0.68 | 0.00 |
| EPS Diluted Total Ops | 0.63 | 0.73 | -0.23 | 0.68 | 0.00 |
| EPS Diluted Continuous Ops | 0.66 | 0.73 | -0.23 | 0.68 | 0.00 |
| EBITDA(a) | $1,206,500 | $1,117,400 | $1,046,600 | $1,004,500 | $1,081,699 |